SARS-CoV-2 VACCINE
Canada
3170322
Filed on 2021-02-11
3170322
Filed on 2021-02-11
SARS-CoV-2 VACCINE
Brazil
BR112022015628-6
Filed on 2021-02-11
BR112022015628-6
Filed on 2021-02-11
SARS-CoV-2 VACCINE
Australia
2021221127
Filed on 2021-02-11
2021221127
Filed on 2021-02-11
SARS-COV-2 VACCINE
US Application 17/798,021
Filed on 2022-08-05
Filed on 2022-08-05
NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE
US Application 17/855,553
Filed on 2022-06-30
Filed on 2022-06-30
VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE
US Patent 11,992,523
Filed on 2022-06-27
Filed on 2022-06-27
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
US Patent 12,054,519
Filed on 2022-06-28
Filed on 2022-06-28
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof
Australia
2022246465
Filed on 2022-10-07
2022246465
Filed on 2022-10-07
Novel Multivalent Nanoparticle-Based Vaccines
Israel
294189
Filed on 2022-06-21
294189
Filed on 2022-06-21